Emergent BioSolutions, Inc. (EBS)
11.62
-0.25
(-2.11%)
USD |
NYSE |
Dec 09, 16:00
11.61
-0.01
(-0.09%)
Pre-Market: 20:00
Emergent BioSolutions Shareholders Equity (Quarterly): 582.50M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Abbott Laboratories | 50.95B |
| SIGA Technologies, Inc. | 203.48M |
| Tonix Pharmaceuticals Holding Corp. | 231.14M |
| GeoVax Labs, Inc. | 4.907M |
| Black Diamond Therapeutics, Inc. | 126.15M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.461B |
| Total Liabilities (Quarterly) | 878.50M |
| Debt to Equity Ratio | 1.152 |
| Current Ratio | 5.765 |
| Net Debt Paydown Yield | 8.86% |